172 related articles for article (PubMed ID: 30690883)
1. WT1-interacting protein inhibits cell proliferation and tumorigenicity in non-small-cell lung cancer via the AKT/FOXO1 axis.
Wu Z; Qiu M; Mi Z; Meng M; Guo Y; Jiang X; Fang J; Wang H; Zhao J; Liu Z; Qian D; Yuan Z
Mol Oncol; 2019 May; 13(5):1059-1074. PubMed ID: 30690883
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Tao JL; Luo M; Sun H; Zhao HM; Sun QS; Huang ZM
Kaohsiung J Med Sci; 2020 Jun; 36(6):417-422. PubMed ID: 32052576
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin specific peptidase 49 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Shen WM; Yin JN; Xu RJ; Xu DF; Zheng SY
Kaohsiung J Med Sci; 2019 Jul; 35(7):401-407. PubMed ID: 31001918
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
[TBL] [Abstract][Full Text] [Related]
6. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
Xu X; Jiang J; Yao L; Ji B
Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
[TBL] [Abstract][Full Text] [Related]
7. Critical role of miR-155/FoxO1/ROS axis in the regulation of non-small cell lung carcinomas.
Hou L; Chen J; Zheng Y; Wu C
Tumour Biol; 2016 Apr; 37(4):5185-92. PubMed ID: 26548866
[TBL] [Abstract][Full Text] [Related]
8. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
9. Expression and localization of FOXO1 in non-small cell lung cancer.
Maekawa T; Maniwa Y; Doi T; Nishio W; Yoshimura M; Ohbayashi C; Hayashi Y; Okita Y
Oncol Rep; 2009 Jul; 22(1):57-64. PubMed ID: 19513505
[TBL] [Abstract][Full Text] [Related]
10. WTIP upregulates FOXO3a and induces apoptosis through PUMA in acute myeloid leukemia.
Zhu Y; Tong X; Wang Y; Lu X
Cell Death Dis; 2021 Dec; 13(1):18. PubMed ID: 34930905
[TBL] [Abstract][Full Text] [Related]
11. SIRT3 is correlated with the malignancy of non-small cell lung cancer.
Xiong Y; Wang M; Zhao J; Wang L; Li X; Zhang Z; Jia L; Han Y
Int J Oncol; 2017 Mar; 50(3):903-910. PubMed ID: 28197634
[TBL] [Abstract][Full Text] [Related]
12. FOXO1 Inhibits Tumor Cell Migration via Regulating Cell Surface Morphology in Non-Small Cell Lung Cancer Cells.
Gao Z; Liu R; Ye N; Liu C; Li X; Guo X; Zhang Z; Li X; Yao Y; Jiang X
Cell Physiol Biochem; 2018; 48(1):138-148. PubMed ID: 30001537
[TBL] [Abstract][Full Text] [Related]
13. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
14. TRIM45 Suppresses the Development of Non-small Cell Lung Cancer.
Peng X; Wen Y; Zha L; Zhuang J; Lin L; Li X; Chen Y; Liu Z; Zhu S; Liang J; Zhou Z; Yuan W; Li Y; Wang Y; Jiang Z; Mo X; Wan Y; Shi Y; Zhu P; Zheng L; Tang C; Wu X; Fan X
Curr Mol Med; 2020; 20(4):299-306. PubMed ID: 31663468
[TBL] [Abstract][Full Text] [Related]
15. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.
Lin Z; Xiong L; Lin Q
Med Oncol; 2015 Jul; 32(7):183. PubMed ID: 26008152
[TBL] [Abstract][Full Text] [Related]
17. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
Wang C; Li S; Xu J; Niu W; Li S
Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.
You W; Chen B; Liu X; Xue S; Qin H; Jiang H
Sci Rep; 2017 Apr; 7(1):591. PubMed ID: 28377627
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
20. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
